In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci
- 30 September 1993
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 17 (2) , 151-155
- https://doi.org/10.1016/0732-8893(93)90026-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628Diagnostic Microbiology and Infectious Disease, 1991
- In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinAntimicrobial Agents and Chemotherapy, 1991
- In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agentAntimicrobial Agents and Chemotherapy, 1991
- Resistance of enterococci to glycopeptidesAntimicrobial Agents and Chemotherapy, 1990
- WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogensAntimicrobial Agents and Chemotherapy, 1990
- Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agentAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditisAntimicrobial Agents and Chemotherapy, 1987
- Clinical experience with ciprofloxacin in the USAEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazoleAntimicrobial Agents and Chemotherapy, 1985
- Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1984